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ABSTRACT
T
he evolution of pathogens presents a paradox.
Pathogenic species are often absolutely dependent
on their host species for their propagation through
evolutionary time, yet the pathogenic lifestyle requires that
the host be damaged during this dependence. It is clear that
pathogenic strategies are successful in evolutionary terms
because a diverse array of pathogens exists in nature.
Pathogens also evolve using a broad range of molecular
mechanisms to acquire and modulate existing virulence traits
in order to achieve this success. Detailing the beneﬁt of
enhanced selection derived through virulence and
understanding the mechanisms through which virulence
evolves are important to understanding the natural world and
both have implications for human health.
Introduction
The Earth provides an environment with considerable
heterogeneity. Commensurate with this, the Earth is
inhabited by an outstanding array of species, varying
signiﬁcantly in complexity and design. The vast majority of
these species are part of an intricate network involving direct
and indirect interactions that constitute the global ecosystem.
Highlighting the span of this network, the environmental
niches occupied by some species extend to niches present
either on or within other species. These interactions
generally fall into categories such as symbiosis/mutualism,
commensalism, or parasitism. The species participating in
these direct interactions range from viruses to metazoans, act
in various capacities, and in some instances involve three or
more species. It may be useful to consider that the
categorisation of these direct interspecies interactions as
mutualism, commensalism, or parasitism represents a
qualitative simpliﬁcation.
In addition to their intrinsic interest, instances where
humans act as host in parasitic interactions are signiﬁcant for
human health. Throughout history, humanity has been
afﬂicted by many of the infectious diseases that we refer to
here. More recently, improved public health and therapeutic
interventions have decreased the impact of infectious
diseases on human health. Nonetheless, the signiﬁcance of
infectious diseases as a cause of human mortality is
underscored by World Health Organization statistics for the
year 2002, which state that infectious diseases resulted in
more years-of-life-lost than all non-communicable diseases
across the globe. The impact of infectious disease on human
health is widely considered to be increasing, in part through
failure of previously efﬁcacious therapeutics. This in itself is a
prime demonstration of how species can evolve to ﬁll an
empty environmental niche. The motivation to understand
how parasitic relationships are maintained is obvious given
the toll infectious diseases take on human health. However,
the intellectual approach taken to study parasitism is perhaps
most effective when an anthropocentric view is rejected in
favour of an ecological view [1].
Parasitism is merely one example of how species exist in
nature. It exempliﬁes the capacity of organisms to evolve
forms able to ﬁll different environmental niches. All species
have resulted from a ‘‘struggle for existence’’ [2]. As originally
postulated, this theory would lead us to believe that species
have been shaped through competition to exist in particular
environmental contexts. Pathogens exist in this same
evolutionary framework, and in this review we will discuss the
selective pressures applied to pathogens and the evolutionary
mechanisms used by pathogens to overcome these pressures.
In the literature to date, each of these topics is generally
discussed with little consideration for the other. By
considering selection and mechanisms of evolution together,
we hope to provide an appropriate contextual starting point
for an all-encompassing view of pathogen evolution.
Definitions
It will be useful to the reader to understand our deﬁnitions
of virulence and pathogen because various deﬁnitions of these
terms are used in the ﬁeld of infectious disease and pathogen
biology. It is not, however, our intention to redeﬁne these
terms for the ﬁeld.
Virulence. Deﬁnitions of virulence typically relate to the
capacity of a pathogen to cause damage or disease in the host
[3,4]. Essentially this is related to the cost to the host. A
frequent measure of virulence is the mortality rate associated
with infection from a pathogen, although it is important to
consider alternative measures in some circumstances [4–11].
For the purpose of this article, we suggest a slight
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should be deﬁned as the damage to the host during infection
with a pathogen. This deﬁnition provides clarity in the many
instances where pathogens themselves do not actively cause a
great deal of damage, rather the damage is caused by the host
response. Despite common discussion of pathogenicity and
virulence as deﬁning slightly different characteristics [3], we
consider this to be unclear and argue that pathogenicity and
virulence are synonymous.
Pathogen. The deﬁnition of pathogen has been discussed in
detail with some degree of disagreement [3,12]. We deﬁne a
pathogen as an organism capable of colonising a host
organism where the interaction results in disease.
Consequently for the purpose of this review, it is the diseased
host that is integral to the deﬁnition of pathogen. Casadevall
and Pirofski had concern that deﬁning a pathogen as an
organism that causes disease in a host was inadequate because
some pathogens don’t cause disease in all hosts [3]. This
concern is unnecessary when one considers that hosts differ,
both within the same species, and especially between
different species. For example, Pseudomonas aeruginosa causes
disease in individuals with burns or cystic ﬁbrosis but does
not cause disease in healthy individuals.
Koch’s postulates either cannot be ethically tested in the
case of human-speciﬁc pathogens, or care must be taken to
select the appropriate host to test the virulence of a pathogen
that affects other hosts. This is frequently a challenge for the
experimentalist and Koch’s postulates cannot be applied to
provide a categorisation of a species as being pathogenic.
The conditional capacity for pathogens to be involved in
interactions that result in disease has led to the use of
adjectives to help describe the circumstances where a
pathogen is associated with disease. A commonly used
adjective is opportunistic. This is typically applied to pathogens
that cause disease only in hosts that are
immunocompromised or whose pathogenesis is facilitated by
traumatic breaching of an epithelial barrier. These organisms
are frequently commensal, i.e., colonise a ‘normal’ host with
no detrimental outcome for the host [12]. A less commonly
used adjective is accidental. This refers to pathogens that are
adapted to one particular host, in either a parasitic,
commensal, or symbiotic relationship, but when infecting a
host that the pathogen does not ordinarily encounter, a
disease results [13]. For example, zoonotic pathogens can be
considered accidental because they have usually not adapted
to the accidental host in a manner allowing efﬁcient
transmission. It is apparent that some of the terminology
used in the ﬁeld of infectious disease research is unclear.
Recent attempts to clarify this situation have been inadequate
for contemporary research [3,14], and it would perhaps be
useful for this matter to be revisited in a work focussed on
developing a unifying lexicon for use in scientiﬁc discourse
on pathogens.
Selection for Virulence
When discussing how virulence traits beneﬁt pathogens, it
is important to consider the pressures applied during the
entire life cycle of the pathogen (Figure 1). The pathogen life
cycle can vary considerably, from complex multiple-host life
cycles of many helminths to direct host-to-host life cycles of
sexually transmitted pathogens. Additionally, certain
pathogens such as the bacterial species Vibrio cholerae, exist
successfully in a non-host aquatic environment [15]. In simple
terms, the evolutionary success of most pathogens requires
efﬁcient iteration of its life cycle. How the virulence of a
pathogen affects this success is discussed below.
The existence of pathogens has often been viewed
throughout history as being a transient step during evolution
to a commensal state. The argument for this frequently states
that parasitic interactions are poorly adapted interactions
that are relatively young in evolutionary terms. Following
from this, as time proceeds the pathogen is hypothesised to
evolve to a commensal state through progressively decreased
virulence [16,17]. This wholesale view is now widely
disregarded. Typically, in instances of direct interactions
between species, simple boundaries can be drawn to
distinguish commensal behaviours from parasitic behaviours.
By and large, commensal behaviour does not involve
colonisation of privileged sites in the host and hence does not
elicit a strong inﬂammatory response.
DOI: 10.1371/journal.ppat.0020042.g001
Figure 1. Flow Diagram of a Generic Pathogen Life Cycle Indicating the Selective Pressures That Have Been Suggested or Shown to Be Important in
Shaping Pathogen Virulence
The filled ellipse represents host species A (the major host), and the filled rectangle represents host species B (the novel host).
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colonisation of privileged sites and, as such, the host responds
with a vigorous inﬂammatory response. Pathogens always
display parasitic behaviour, and may in addition display
commensal behaviour. Therefore, pathogens and commensals
do not compete in most instances except where an epithelial
surface must be colonised during initial stages of
pathogenesis. Many pathogens do not display any behaviours
associated with commensalism, hence evolution to a
commensal state would typically involve adaptation to an
entirely different environment within a host as well as the
development of strategies to allow success when competing
against the microbiota at that site. This would have to occur
rapidly in order to provide substantive beneﬁt to support
selection of such traits. Whilst this is possible, a more likely
occurrence would be an increase in the efﬁciency of the
pathogenic strategy that would be selected at the expense of
the less efﬁcient progenitor. In the case of opportunistic
pathogens, which clearly can display commensal and parasitic
behaviours, it is more difﬁcult to hypothesise. Many
opportunistic pathogens appear to rely more on
commensalism for survival. With virulence strategies playing
a largely unknown role in the propagation of these species
(see below), the role for virulence in the survival of these
species is largely unknown. Clearly, if virulence strategies
were important to the propagation of an opportunistic
pathogen, an increase in the efﬁciency of these strategies
would be expected to enhance the success of the species.
In understanding how virulence might be selected, it is also
necessary to understand the implications of virulence
mechanisms during the infectious stage of the infection. The
symptoms associated with certain diseases may directly
facilitate the spread of the pathogen; for example, respiratory
infections that result in coughing and sneezing [18]. This sign
of infection is the result of pathogen virulence mechanisms
and is hypothesised to increase the output of the pathogen
for subsequent infection of new hosts. Hence, higher
efﬁciency of such virulence mechanisms would be expected to
out-compete lower efﬁciency, as it would increase the output
of the pathogen for transmission. However, there are
numerous virulence strategies that do not appear to provide
an obvious selectable advantage, such as when pathogens
replicate at sites of the host from where the pathogen is not
transmitted [11]. Many examples of this are opportunistic
pathogens, which have both commensal and parasitic traits
where the commensal colonisation of an epithelial surface
can account for the spread of such species between hosts, and
hence the existence of such species. Nonetheless, the question
remains, how are the virulence traits of these organisms
positively selected? In such instances, a virulence factor would
be selected if it were beneﬁcial at other important stages of
the pathogen life cycle, including non-host stages. The beneﬁt
granted to clones at non-transmissible sites in the host would
be short-term and a dead end. Alternatively, the pathogen
populations at sites in the host thought to be unimportant for
transmission to new hosts may actually form a reservoir for
trafﬁc to sites of the host that are competent for spread. A
better understanding of the biology of these relationships will
likely provide more rational hypotheses.
If virulence is positively selected as suggested by most
modern theorists, this suggests that a relationship exists
between virulence and pathogen load in the host. How closely
related is virulence to the ability to replicate to relatively
large numbers within a host? It is important to consider the
ability to replicate as being more complex than a simple
reﬂection of the efﬁciency of generic, core metabolism. Many
pathogen-speciﬁc processes are involved, including, for
example, evasion of the immune system. It would be expected
that if a given pathogen acquired an adaptation allowing
growth to higher numbers in the host, the cost to the host
would increase, assuming the unit of damage to the host per
unit of pathogen was unchanged. This includes damage
mediated through active pathogen processes, damage
mediated through host responses, and the additional nutrient
burden of supporting the higher load of pathogens. In many
host–pathogen systems this logic holds true, high pathogen
burden indeed positively correlates with virulence, though
this is often not directly discussed [4,17,19]. For this to
translate into a selectable advantage in the longer term, it
must increase the efﬁciency of the pathogen life cycle as a
whole in a sustainable manner.
An important factor that is theorised to modulate the
virulence of a successful pathogen is the mode of transmission.
A common comparison is the virulence of vector-borne
pathogens versus directly transmitted pathogens. It has been
hypothesised that vector-borne pathogens allow for the
selection of higher virulence levels than those that are directly
transmitted [20,21]. This hypothesis assumes that increased
virulence is associated with a reduction in normal host
behaviours and mobility [21]. The higher virulence of vector-
borne pathogens is afforded by transmission being less
dependent on host mobility, and may even be enhanced by a
reduction in host mobility increasing exposure to vectors. In
contrast, direct transmission commonly requires active host
behaviours to expose naive hosts to the pathogen. An
alternative comparison is between horizontal and vertical
transmission. While vertical transmission is not infectious,
there are various direct interactions between species where
transmission is strictly vertical. These pathogens rely on
infected-host reproduction to propagate themselves, and as
such the success of such pathogens is linked to the
evolutionary success of infected hosts. It is predicted that
vertically transmitted pathogens should evolve towards lower
virulence, allowing greater success of their hosts. Using barley
stripe mosaic virus infection of Hordeum vulgare, it has been
found in that vertical transmission evolves towards decreased
virulence whilst horizontal transmission evolves towards
increased virulence [22].
A concept related to the association of virulence with mode
of transmission is the capacity of the pathogen to survive in
the external environment [16]. In a retrospective study of
various human respiratory pathogens, a positive correlation
between environmental (non-host) survival time and
pathogen virulence was obtained [7]. This suggests that
species capable of long-term environmental survival are less
dependent on direct infected-host-to-uninfected-host
contact for transmission and are able to evolve to higher
relative virulence levels. Similar to the hypothesis for vector-
borne pathogens, as a pathogen becomes less dependent on
normal host function for transmission, a higher pathogen
burden is positively selected, and this correlates with
increases in virulence. A general strategy of horizontally
transmitted pathogens during infection would be to produce
the largest number of infectious particles per infected host
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this may be achieved in a short period of time by reaching
very high pathogen burdens during infection and waiting out
a longer non-host phase for subsequent infections. An
example of a bacterial pathogen using high virulence/long
extra-host survival strategy would be Bacillus anthracis, which
is extremely virulent and produces durable, long-lived
endospores during non-host phases [7]. Conversely,
pathogens with short extra-host survival times would rely on
closer contact between hosts, at least in a temporal sense. This
would necessitate relatively normal host function and a
longer duration of infection, hence lower virulence, where
the chances of productive host–host contacts would be
maximised. Mycoplasma pneumoniae represents a good example
of this strategy, typically causing a mild disease commonly
referred to as walking pneumonia and having a short-lived
and sensitive non-host phase [7].
Much of the above discussion on selection refers exclusively
to species that are adapted to a particular host species. What
of the selective pressures applied to accidental pathogens as
they forge new ground in a previously unencountered host
species? This may be quite common and therefore should be
considered an important aspect of pathogen evolution. The
most restrictive barriers to extending the host range of a
pathogen are exposure to other host species, obviously the
ability to colonise by the pathogen must be efﬁciently
transmitted to subsequent hosts. Establishment in a new host
species depends on numerous variables linked to the
susceptible host population size and density, infection
dynamics relating virulence to the spread of the pathogen
and so forth [23]. The pathogen may become endemic,
epidemic, or somewhere in between. Newly adapted
pathogens that cause epidemics may become extinct, as
occurred with the 1918 pandemic strain of inﬂuenza virus
[24]. Once established with a degree of endemicity, pathogen
virulence would then be subject to the selective pressures
discussed above, where sibling clones compete with each
other for natural selection.
Box 1. Making Use of Morons
Morons are genes located between two genes whose
homologues are adjacent in related phage [62]. These genes
have no direct role in the lytic or lysogenic developmental cycles
of the phage, but rather serve as fitness factors for the lysogen
via the advantage they afford to the bacterial host. By
contributing to the survival of their bacterial host, morons are
positively selected. In many ways, virulence genes associated
with all mobile genetic elements that are not required for the
process of element mobilisation and/or replication could be
considered analogous to phage morons.
It was clear from early work on bacterial pathogens such as
Salmonella and Escherichia coli that genes required for particular
biochemical pathways tend to cluster together [63,64]. This
clustering of genes of related function into operons, both
essential and non-essential, has been argued to be formed by
horizontal gene transfer [65] or by co-regulation [66], but what is
apparent is that once gene clusters have formed, they can be
moved as a unit by horizontal gene transfer between pathogens.
This clustering would facilitate the utilization by the host of the
functions encoded by the newly acquired DNA.
Barriers exist to the use of horizontally acquired genes
following their acquisition. If the genes transferred confer no
added fitness, they will likely be lost by random mutation or
deletion. Likewise, if the transferred genes reduce the fitness of
the new host, they will be lost in the competition with non-
converted bacteria. Since the organism into which gene transfer
has occurred possesses a biochemical network that has itself
been honed and balanced by evolution, the question of how
host organisms take advantage of these morons becomes a
pivotal one to the evolution of virulence.
Horizontally transferred regions may encode regulators that
control the expression of genes within the transferred DNA [67].
However, this does not automatically result in appropriate
contextual expression in the regulatory network of a cell. A
possible solution to this problem would be to co-opt ancestral
regulatory mechanisms already present in the genome of the
recipient in order to achieve a profitable expression pattern.
Evidence for such occurrences are provided in several bacterial
pathogens that incorporate horizontally acquired genes into
their virulence program, such as utilization of the OmpR/EnvZ
and PhoP/PhoQ two-component regulatory systems by
Salmonella for coordination of its two type III secretion systems
required for pathogenesis [68–70]. Ancestral transcriptional
repressors have also been commandeered, such as H-NS [71],
YmoA [72,73], Hha [74], and YdgT [75] to fine-tune the
expression of virulence factors contained within HGT regions.
That these co-opted regulators are as important as the presence
of virulence factors themselves is highlighted by the attenuated
phenotype of mutants lacking proper regulation.
The utilization by a pathogen of newly recruited virulence
factors sometimes necessitates the presence of a delivery system
competent to localise the molecule appropriately. One way
bacterial pathogens have solved such a problem is to evolve a
protein delivery channel on their surface, allowing for
translocation of proteins (termed effectors) directly into target
host cells. This system is usually encoded within a single locus
containing a set of operons. Once this system is in place, new
effectors can be added by horizontal transfer in a plug-and-play
manner once appropriate regulation and targeting of effectors to
the type III system is achieved. The phage protein SopE,
associated with the Salmonella prophage SopEU [76] can be
movedbylysogenyintovariousstrainsandsecretedbythetypeIII
secretion system. Another phage moron, called GogB, associated
with the Gifsy-1 prophage in some strains of Salmonella enterica,
can be experimentally transferred to enteropathogenic E. coli as a
discrete module where it immediately integrates into the EPEC
type III secretion system at the level of co-regulation, targeting,
and secretion [77].
The acquisition of appropriate regulation by horizontally
transferred fitness factors, such as type III effectors, is as
pivotal to the evolution of virulence as the acquisition of the
virulence factors themselves. While an important long-
standing question has been the unknown origin of
horizontally acquired virulence factors, an equally important
question is how regulatory elements become installed to
result in effective expression.
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While it is indeed important to consider the entire life cycle
of pathogens, it is the nature of their interaction with hosts
that deﬁnes them as pathogens; consequently, this interaction
has provided immense selection pressure for pathogen (and
host) evolution. Invertebrate and vertebrate hosts possess an
innate immune system to deal with pathogens; however, this
system lacks speciﬁcity. Vertebrates possess the additional
and superior protection of an adaptive immune response that
has memory over individuals’ lifetimes. While our genomes
bear the marks of selection resulting from co-evolution with
pathogens [25–32], fortunately for pathogens of vertebrates,
the somatic mutation pivotal to the generation of adaptive
immune responses is not heritable, therefore each generation
presents itself as naive hosts susceptible to infection. Given
the array of strategies pathogens have evolved to deal with
host immune responses, it is clear that this has selected for
pathogens able to cope with immune assault.
Antigenic variation has convergently evolved in many
pathogens as a strategy allowing infection of hosts with prior
exposure and for infections to persist longer (and in some
cases to become chronic). Antigenic variation can be deﬁned
as the ability of pathogens to vary the antigens it exposes to
the host, by differential expression of antigens belonging to
the same family. The molecular mechanisms that govern this
Box 2. Has the Struggle between Host Resistance and Mobile Genetic Element Given Rise to Virulence?
William Hayes, who pioneered work on conjugative gene
transfer (convergent with the work of the Lederbergs and Cavalli
[78]), has suggested that with regard to bacterial genomes, it is
no longer possible for us to ‘draw a firm line of demarcation
between chromosomal and cytoplasmic determinants, between
viral and non-viral elements, or even between viral and bacterial
genes’ [79]. Already, genetics had made it clear that genes may
spread throughout different bacterial species via natural
transformation, transduction, and conjugation.
Over the last 20-odd years, it has become even clearer that
bacterial pathogens contain an amazing array of horizontally
acquired DNA. Amongst these regions of DNA are not only selfish
DNA molecules (which contain only the elements required for
mobilisation and do not contribute to the fitness of the host) such
as IS elements (which some might argue could be the simplest
form of life), but also transposons, plasmids, prophages, and
regions known as genomic islands (some of which may also be
regardedasselfishDNA);allofwhichcanharbourvirulencegenes.
Since these regions of DNA have been acquired horizontally,
their presence infers that within these regions are one or more
genes that increase the fitness of bacteria harbouring this region
of landed foreign DNA. Thus the advantage conferred by these
genes has presumably selected for the spread of the mobile
regionsofDNAtheyresidein.Thesheervolumeofhorizontalgene
transfer inferred from sequence gazing suggests that this process
is pivotal to the evolution of virulence, but an important
unanswered question is what facilitates this spread at the
molecular level.
Of course, it is in part the immune response to pathogens that
provides the selective pressure for the acquisition of virulence
factors that facilitate colonisation in the face of this immune
assault. But might the immune response promote the
dissemination of mobile genetic elements and the virulence
factors they contain in a more direct sense, by stimulating their
mobilization? Were this to be the case, mobile genetic elements
wouldappeartohavenotonlyhaveco-optedbacteriabutalsothe
parasitised host in their struggle for existence. As a consequence,
disease and the evolution of bacterial pathogenicity may be an
unfortunatebutnecessaryresultofthebattlebetween parasitised
host and mobile genetic elements.
Work comparing DNA mutation rates of pathogens suggests
mutation rates are higher when pathogens are within a host
context [57]; could this be indicative of the stress of dealing with
immune assault? Phage that encode virulence determinants
such as Shiga-toxin have been shown to lysogenise commensal
E.coli invivo[80]. Thatsuchtransfereventsoccur atamuchhigher
frequency in vivo than in vitro [81] suggests there is indeed
something about the host that promotes the spread of phage
containing fitness factors. What are the host agents that promote
the movement of mobile genetic elements?
One candidate is reactive oxygen species produced by
phagocytes; which has been shown to induce a lytic stage in both
E. coli and Salmonella prophages [82,83]. From the bacterial side,
thebacterialSOSresponsetoDNAdamagehasbeenimplicatedin
the induction of phage transfer [84–87]. In addition, this SOS
response also facilitates horizontal transfer of conjugative
elements[88],suggestingmobilegeneticelementshaveco-opted
a global response to DNA damage to regulate their escape from
damaged (bacterial) hosts. The ability of agents that induce the
SOS response, such as reactive oxygen species, mitomycin C, and
antibiotics (including fluoroquinolone antibiotics and DHFR
inhibitors), to facilitate conjugative transfer suggests that transfer
may be promoted by any agent that induces the SOS response.
It is possible that other components of the innate immune
system promote mobilegenetic elementtransferinvivo. Defective
cellwallsynthesis(suchasthatinducedbyB-lactamantibiotics)has
been shown to initiate the SOS response, allowing bacteria to
survivelongerinthepresenceofanantibiotic[89].Giventhatmany
antimicrobial peptides, molecules central to the innate immune
system, inhibit cell wall synthesis or impair bacterial cell septum
formation [90–93], it is possible that antimicrobial peptides also
inducethebacterialSOSresponse.Asaconsequence,antimicrobial
peptides may facilitate the transfer of mobile genetic elements
between bacteria, although this important possibility remains
unaddressedinanymodelsystem.Theavailabilityofmicedeficient
in particular antimicrobial peptides should allow dissection of the
importance of these molecules in mobilisation of transferable
virulence genes.
The innate immune response has selected for the
dissemination of mobile genetic elements by virtue of
providing selection for the virulence genes contained within
them (i.e., the advantage these genes afford to the pathogen).
If antimicrobial peptides were able to promote the transfer of
mobile genetic elements in vivo, it may be that mobile
genetic elements not only sense (indirectly) the innate
immune response [94] but utilise it towards their own end, to
spread amongst the ranks of pathogen that struggle for
existence.
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inversion [33–38], gene conversion [39,40], through to
epigenetic factors such as subnuclear localization and histone
acetylation, and Dam methylation [41–43]. Another strategy
evolved to counter the immune response is the ability to
directly modulate host immune responses via pathogen-
encoded homologues of immune modulators such as Fc
receptors and cytokines (reviewed elsewhere [44–46]).
Not only are the generative mechanisms that drive genetic
variation pivotal to the evolution of virulence, the expression
of these changes is equally important (see Box 1). Selection is
thought to favour haploidy in pathogens and diploidy in hosts
[47], suggesting that limiting the array of antigens exposed to
the host during infection is a driving force for the pathogen
during infection. Obviously, the beneﬁt of haploidy is the
immediate phenotypic expression of genetic variations; the
consequent beneﬁts (or costs) of these mutations through
selection within the host will determine the success of these
changes. Diploidy in pathogens would be expected to buffer
the phenotypic expression of genetic variation, thereby
slowing pathogen evolution.
Amongst the mechanisms of change at the simplest level
are point mutation, base substitution, and recombination.
Consequently, the rate by which a pathogen is capable of
change is encoded in the pathogen’s genome (by virtue of the
error rates of the molecules and enzymes governing these
processes). This simple but important concept infers that the
rates of change are themselves subject to natural selection
(i.e., that evolvability itself is subject to natural selection) [48].
Within the framework of evolvability being a selectable trait,
it is fascinating to see that while mutations in the molecules
that govern the repair of mutations (resulting in a
hypermutable state) are rare in vitro [49] and deleterious [50]
they appear with higher frequencies in hospital environments
[51,52], suggesting that genetic ﬂexibility is advantageous
within hosts to maintain pathogen ﬁtness [53].
It has been clear for some time that different organisms
have different baseline mutation rates [54], but more recently
it has become apparent that mutation rates are not uniformly
distributed across an organism’s genome; for instance, the
complementarity determining regions of immunoglobulin
exhibit higher mutation rates than those in framework
regions [55]. Likewise, pathogens appear to exhibit higher
mutation rates at regions of their genomes involved in
antigenic drift [56]. A second pivotal point is that pathogen
mutation rates appear higher in vivo than in vitro [57],
suggesting that the interaction of pathogen and host itself
facilitates the generation of variation. For bacterial
pathogens, the frequency of horizontal gene transfer (central
to the acquisition of virulence determinants in bacterial
pathogens) appears higher in vivo than in vitro (Box 2),
suggesting that host–pathogen interaction is not only
involved in the selection for pathogen ﬁtness factors, but may
directly contribute to the generation and dissemination of
these ﬁtness determinants.
In bacteria, pathogenicity-associated genes commonly
reside in mobile genetic elements (or their remnants) within
the genomes of pathogens. These mobile genetic elements
include plasmids, phage, conjugative transposons,
transposons, and integrons, all of which can be transferred
between genomes, generating variation. This horizontal gene
transfer (which has been demonstrated experimentally, see
Box 2) is thought to lead to the acquisition of new traits upon
transfer to new hosts, and the prevalence of genomic islands
(and genomic islets) suggests this transfer is widespread [58].
Other pathogens, such as Plasmodium and Trypanosoma, beneﬁt
from a sexual cycle and the recombination between genomes
it provides [59,60]. Likewise, viruses that infect the same cell
can recombine genomes, often resulting in the antigenic shift
associated with virulent strains. Gene acquisition such as this
has profound effects by allowing pathogens to evolve rapidly
to overcome selective pressures.
Applications and Future Challenges
The processes of selection and evolution of virulence traits
is a continuum, inﬂuenced by both deterministic and
stochastic events that are interminable. However, one thing is
clear; the evolution of hosts and the pathogens that exploit
them are inexorably linked. The genetic composition of
individual hosts shape and ﬁne-tune pathogen virulence, and
the reciprocal genetic sculpting process is also true.
Harrowing for us, bacterial pathogens possess consummate
skill at testing the waters, using genetic elements acquired
from external reservoirs, followed by diversiﬁcation in
various ecological niches that ultimately maximize their
propagation and transmission. Intense effort is underway to
learn what portions of DNA harbour the salient features of
host defences and pathogen virulence, and accomplishments
towards this goal will continue as genomics and
bioinformatics fertilise the ﬁeld of evolutionary biology.
Increasing knowledge of how pathogen virulence traits are
acquired and selected in various populations is consequential
for several reasons. In practical terms relating to global
human health, it is apropos to bring to bear information
concerning the evolution and maintenance of pathogen
virulence traits to applied ends. Policies governing infection
control programs and intervention scenarios ought to be
instructed by evidence-based data on how pathogens persist
in human populations, how such infections are spread
amongst the population, and which animal or environmental
reservoirs might contribute to the spread. Novel approaches
to quantifying the spread of infection based on surveillance,
contact tracing [61], and geographical patterns of
transmission are being implemented, taking into account
stochastic events during early stages of pathogen transmission
that are difﬁcult to model. The incorporation of genomic
data into such models should be a beneﬁt to pathogen
surveillance efforts and risk assessment strategies. This
presupposes that quantitative and qualitative measures of
risk associated with certain genetic elements within
pathogens are developed, and indeed the genomics era has
facilitated this.
The challenge for future research is to take the basic
concepts of evolutionary biology beyond the selection and
maintenance of virulence traits and apply these principles
towards logical predictions of how certain pathogens will
behave in a population over evolutionary time. Progress
towards this end requires collaboration among evolutionary
biologists, epidemiologists, social scientists, and basic
scientists. Deﬁnitive answers to how and where pathogens
acquire new genetic material, how these genes are expressed
and selected for, and the relative risks associated with certain
genetic elements will allow a more complete comprehension
of the evolution of infectious diseases. “
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